All > Prediabetes > Overweight

Modified DPP for Prediabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Prediabetes+1 MoreModified Diabetes Prevention Program Curriculum - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to demonstrate the efficacy of the diabetes prevention program for the treatment of overweight and obesity within the community pharmacy setting. The long-term goal is to demonstrate the potential to improve diabetes prevention efforts through expanded access to weight loss services provided in community pharmacies.

Eligible Conditions
  • Prediabetes
  • Weight Loss

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Intravenous fluids
1
Guselkumab
1
VAL-083

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: 1 year

1 year
Reasons for participation/non-participation
3- and 6- months
Change in A1c
6 months
Blood pressure change
Change in Processes of Change for Weight Loss including the following processes: emotional re-evaluation, weight consequences evaluation, supporting relationships, and weight management actions
Change in Stage of Change for Weight Loss
Change in level of confidence in ability to motivate oneself to maintain dietary and physical activity behaviors for at least 6 months
Participation and attrition
Physical activity change
Weight loss
Month 3
Proportion of patients meeting DPP program criteria

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Intravenous fluids
2
Guselkumab
2
VAL-083

Trial Design

1 Treatment Group

Modified DPP
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: Modified DPP · No Placebo Group · N/A

Modified DPP
Behavioral
Experimental Group · 1 Intervention: Modified Diabetes Prevention Program Curriculum · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

Auburn UniversityLead Sponsor
52 Previous Clinical Trials
13,649 Total Patients Enrolled
Courtney E Gamston, PharmDPrincipal InvestigatorAuburn University Harrison School of Pharmacy

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top